Financing · May 20, 2026

Gilead Sciences has entered into an agreement to issue $3 billion in aggregate principal amount of senior notes to…

GILDGilead Sciences, Inc.

Gilead Sciences has entered into an agreement to issue $3 billion in aggregate principal amount of senior notes to fund general corporate purposes. The offering consists of $500 million due 2028 at 4.250%, $1 billion due 2029 at 4.400%, $1 billion due 2031 at 4.600%, and $500 million due 2034 at 4.900%.